Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Abvc Biopharma (ABVC) over the last 2 years, with Q3 2024 value amounting to -$730049.0.

  • Abvc Biopharma's Treasury Shares rose 8.22% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 8.22%. This contributed to the annual value of $8.9 million for FY2024, which is 9.01% up from last year.
  • Latest data reveals that Abvc Biopharma reported Treasury Shares of $8.9 million as of Q3 2025, which was up 8.22% from $8.9 million recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Treasury Shares peaked at $9.1 million during Q1 2021, and registered a low of $8.9 million during Q4 2023.
  • For the 5-year period, Abvc Biopharma's Treasury Shares averaged around $9.0 million, with its median value being $9.1 million (2021).
  • Per our database at Business Quant, Abvc Biopharma's Treasury Shares crashed by 217.95% in 2023 and then grew by 9.01% in 2024.
  • Abvc Biopharma's Treasury Shares (Quarter) stood at $9.1 million in 2021, then changed by 0.0% to $9.1 million in 2022, then dropped by 2.18% to $8.9 million in 2023, then increased by 0.09% to $8.9 million in 2024, then changed by 0.0% to $8.9 million in 2025.
  • Its Treasury Shares was $8.9 million in Q3 2025, compared to $8.9 million in Q2 2025 and $8.9 million in Q1 2025.